Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy

American Journal of Physiology - Renal Physiology

Volumn 302, Issue 5, 2012, Pages

  Ju, Kyung Don ^a,b   Shin, Eun Kyoung ^b   Cho, Eun Jin ^a   Yoon, Hyun Bae ^a   Kim, Hyo Sang ^a   Kim, Hwajung ^c   Yang, Jaeseok ^c   Hwang, Young Hwan ^d   Ahn, Curie ^a,c   Oh, Kook Hwan ^a,b  

^a Department of Internal Medicine ^*  (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University   (South Korea)

^d Eulji University   (South Korea)

Author keywords

Antioxidant; Mesangial cells

Indexed keywords

COLLAGEN TYPE 4; ETHYL PYRUVIC ACID; FIBRONECTIN; GLUCOSE; LAMININ; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTECTIVE AGENT; PYRUVIC ACID DERIVATIVE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ALBUMINURIA; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME INHIBITION; GLOMERULOPATHY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; RENAL PROTECTION;

EID: 84863289595     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00415.2011     Document Type: Article

References (41)

1. Abboud HE, Ou S, Velosa J, Shah SV, Dousa TP. Dynamics of renal histamine in normal rat kidney, and in nephrosis induced by aminonucleoside of puromycin. J Clin Invest 69: 327-336, 1982.
2. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412, 1991.
3. Bilous R, Mauer S, Sutherland D, Steffes M. Mean glomerular volume and rate of development of diabetic nephropathy. Diabetes 38: 1142, 1989.
4. Brosius FC. New insights into the mechanisms of fibrosis and sclerosis in diabetic nephropathy. Rev Endocr Metab Disord 9: 245-254, 2008.
5. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
6. Craven PA, DeRubertis FR, Kagan VE, Melhem M, Studer RK. Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-beta, and glomerular size in diabetes. J Am Soc Nephrol 8: 1405, 1997.
7. Cross AR, Segal AW. The NADPH oxidase of professional phagocytes-prototype of the NOX electron transport chain systems. Biochim Biophys Acta 1657: 1-22, 2004.
8. Cui XL, Douglas JG. Arachidonic acid activates c-jun N-terminal kinase through NADPH oxidase in rabbit proximal tubular epithelial cells. Proc Natl Acad Sci USA 94: 3771-3776, 1997.
9. Forbes J, Fukami K, Cooper M. Diabetic nephropathy: where hemodynamics meets metabolism. Exp Clin Endocrinol Diabetes 115: 69-84, 2007.
10. Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57: 1446-1454, 2008.
11. Geiszt M, Leto TL. The Nox family of NAD (P) H oxidases: host defense and beyond. J Biol Chem 279: 51715-51718, 2004.
12. Gorin Y, Ricono JM, Kim NH, Bhandari B, Choudhury GG, Abboud HE. Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am J Physiol Renal Physiol 285: F219-F229, 2003.
13. Ha H, Yu MR, Choi YJ, Kitamura M, Lee HB. Role of high glucoseinduced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells. J Am Soc Nephrol 13: 894-902, 2002.
14. Hinokio Y, Suzuki S, Hirai M, Chiba M, Hirai A, Toyota T. Oxidative DNA damage in diabetes mellitus: its association with diabetic complications. Diabetologia 42: 995-998, 1999.
15. Huang JS, Chuang LY, Guh JY, Huang YJ, Hsu MS. Antioxidants attenuate high glucose-induced hypertrophic growth in renal tubular epithelial cells. Am J Physiol Renal Physiol 293: F1072-F1082, 2007.
16. Inoguchi T, Sonta T, Tsubouchi H, Etoh T, Kakimoto M, Sonoda N, Sato N, Sekiguchi N, Kobayashi K, Sumimoto H. Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD (P) H oxidase. J Am Soc Nephrol 14: S227-S232, 2003.
17. Jones S, Hancock J, Jones O, Neubauer A, Topley N. The expression of NADPH oxidase components in human glomerular mesangial cells: detection of protein and mRNA for p47phox, p67phox, and p22phox. J Am Soc Nephrol 5: 1483-1491, 1995.
18. Lassegue B, Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, regulation. Am J Physiol Regul Integr Comp Physiol 285: R277-R297, 2003.
19. Li JM, Shah AM. ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J Am Soc Nephrol 14: S221-S226, 2003.
20. Melhem MF, Craven PA, Derubertis FR. Effects of dietary supplementation of lipoic acid on early glomerular injury in diabetes mellitus. J Am Soc Nephrol 12: 124-133, 2001.
21. Morrisey K, Steadman R, Williams JD, Philips AO. Renal proximal tubular cell fibronectin accumulation in response to glucose is polyol pathway dependent. Kidney Int 55: 160-7, 1999.
22. Nangaku M. Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern Med 43: 9-17, 2004.
23. Philips AO, Morrisey K, Steadman R, Williams J. Decreased degradation of collagen and fibronectin following exposure of proximal cells to glucose. Exp Nephrol 7: 449-62, 1999.
24. Sano T, Umeda F, Hashimoto T, Nawata H, Utsumi H. Oxidative stress measurement by in vivo electron spin resonance spectroscopy in rats with streptozotocin-induced diabetes. Diabetologia 41: 1355-1360, 1998.
25. Satoh M, Fujimoto S, Haruna Y, Arakawa S, Horike H, Komai N, Sasaki T, Tsujioka K, Makino H, Kashihara N. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol 288: F1144-F1152, 2005.
26. Schnackenberg CG. Oxygen radicals in cardiovascular-renal disease. Curr Opin Pharmacol 2: 121-125, 2002.
27. Schrijvers BF, De Vriese AS, Flyvbjerg A. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors, and growth factors/cytokines. Endocr Rev 25: 971-976, 2004.
28. Song M, Kellum JA, Kaldas H, Fink MP. Evidence that glutathione depletion is a mechanism responsible for the anti-inflammatory effects of ethyl pyruvate in cultured lipopolysaccharide-stimulated RAW 264.7 cells. J Pharmacol Exp Ther 308: 307-316, 2004.
29. Trachtman H, Futterweit S, Maesaka J, Ma C, Valderrama E, Fuchs A, Tarectecan A, Rao P, Sturman J, Boles T. Taurine ameliorates chronic streptozocin-induced diabetic nephropathy in rats. Am J Physiol Renal Fluid Electrolyte Physiol 269: F429-F438, 1995.
30. Ulloa L, Ochani M, Yang H, Tanovic M, Halperin D, Yang R, Czura CJ, Fink MP, Tracey KJ. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci USA 99: 12351-12356, 2002.
31. Varma S, Hegde K, Kovtun S. Oxidative damage to lens in culture: reversibility by pyruvate and ethyl pyruvate. Ophthalmologica 220: 52-57, 2000.
32. Venkataraman R, Kellum JA, Song M, Fink MP. Resuscitation with Ringer's ethyl pyruvate solution prolongs survival and modulates plasma cytokine and nitrite/nitrate concentrations in a rat model of lipopolysaccharide-induced shock. Shock 18: 507-512, 2002.
33. Von Korff R. Pyruvate-C14, purity and stability. Anal Biochem 8: 171-178, 1964.
34. Weigert C, Sauer U, Brodbeck K, Pfeiffer A, Haring HU, Sshleicher ED. AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-beta1 promoter in mesangial cells. J Am Soc Nephrol 11: 2007-2016, 2000.
35. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 43: 801-13, 1993.
36. Williamson JR, Osrow E, Eades D, Chang K, Allison W, Kilo C. Glucose-induced microvascular functional changes in non diabetic rats are stereospecific and are prevented by an aldose reductase inhibitor. J Clin Invest 85: 1167-72, 1990.
37. Wolf G, Ziyadeh FN. Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 56: 393-405, 1999.
38. Yang R, Han X, Delude RL, Fink MP. Ethyl pyruvate ameliorates acute alcohol-induced liver injury and inflammation in mice. J Lab Clin Med 142: 322-331, 2003.
39. Yang R, Uchiyama T, Watkins SK, Han X, Fink MP. Ethyl pyruvate reduces liver injury in a murine model of extrahepatic cholestasis. Shock 22: 369-375, 2004.
40. Ziyadeh F. The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 22: 736-744, 1993.
41. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De la Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci USA 97: 8015-8020, 2000.